Roche Holding AG
RHHVF
$347.00
$8.152.41%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.51% | 7.35% | |||
| Total Other Revenue | -1.51% | 14.22% | |||
| Total Revenue | -1.51% | 7.55% | |||
| Cost of Revenue | -1.51% | 15.56% | |||
| Gross Profit | -1.51% | 4.98% | |||
| SG&A Expenses | -1.51% | 16.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -1.51% | 204.78% | |||
| Total Operating Expenses | -1.51% | 20.09% | |||
| Operating Income | -1.51% | -15.47% | |||
| Income Before Tax | -1.51% | -54.61% | |||
| Income Tax Expenses | -1.51% | -26.01% | |||
| Earnings from Continuing Operations | -1.51% | -61.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 1.51% | -12.17% | |||
| Net Income | -1.51% | -66.27% | |||
| EBIT | -1.51% | -15.47% | |||
| EBITDA | -1.51% | -12.07% | |||
| EPS Basic | -1.51% | -66.27% | |||
| Normalized Basic EPS | -1.51% | -18.47% | |||
| EPS Diluted | -1.51% | -66.36% | |||
| Normalized Diluted EPS | -1.51% | -18.47% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -1.00% | |||
